Company Filing History:
Years Active: 2025
Title: Innovations of Georges Guillaume in Pharmaceutical Technology
Introduction
Georges Guillaume is a notable inventor based in Ophain, Belgium. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of controlled-release drug delivery systems. His innovative approach has the potential to enhance the efficacy of medications and improve patient outcomes.
Latest Patents
Georges Guillaume holds a patent for a groundbreaking invention titled "Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form." This patent describes a controlled-release multilayer microparticle designed for oral administration or direct administration in the stomach. The microparticle consists of a core that includes a pharmaceutically active compound, which may be pramipexole, surrounded by a controlled-release intermediate coating layer and an outer protection coating layer. The outer layer is composed of a mixture of hydrophilic gastro-soluble components and hydrophobic or insoluble components. This invention also encompasses a liquid pharmaceutical composition containing the microparticles, a kit for preparing the liquid composition, and methods for treating diseases with the composition.
Career Highlights
Georges Guillaume is associated with Be Pharbel Manufacturing, where he continues to innovate in the pharmaceutical sector. His work focuses on developing advanced drug delivery systems that can significantly improve the therapeutic effects of medications. With a patent portfolio that includes one patent, he is recognized for his contributions to the field.
Collaborations
Georges has collaborated with notable colleagues such as Jonathan Goole and Karim Amighi. Their combined expertise in pharmaceutical sciences has fostered an environment of innovation and creativity, leading to advancements in drug formulation and delivery.
Conclusion
Georges Guillaume's work in the development of multilayered microparticles represents a significant advancement in pharmaceutical technology. His innovative solutions have the potential to transform how medications are delivered and administered, ultimately benefiting patients worldwide.